The past and the future of cancer genetics (pages 347 to 354)
R. Jankovi (Institute of Oncology and Radiology of Serbia, Beograd, Serbia Montenegro), M. Brankovi-Magi, S. Radulovi
Is Open Access to medical research literature relevant to low- and middle-income countries (pages 355 to 358)
R. King (BioMed Central, London, United Kingdom), P. S. Tamber
Good Scientific Practice. Part IV. Conflict of interest (pages 359 to 362)
Ljiljana Vukovi-Deki (Institute for Oncology and Radiology of Serbia, Beograd, Serbia and Montenegro)
The status of chemoprevention in the current cancer therapeutic armamentarium (pages 363 to 372)
M. V. Karamouzis (First Department of Medical Oncology, St. Savvas Anticancer-Oncologic Hospital, Athens, Greece)
Carcinoma in situ of the urinary bladder (pages 373 to 382)
T. Arvanitakis (Department of Urology, Agios Savvas Cancer Hospital, Athens, Greece), G. Panousakis, C. Lymberakis
The RACOX phase I study radiation (RA), capecitabine (C) and oxaliplatin (OX) as adjuvant treatment of stage II and III rectal cancer (pages 383 to 390)
N. Bountouroglou (Department of Radiation Oncology-A, Metaxa Cancer Hospital, Piraeus, Greece), N. Ziras, G. Sarris, A. Petrides, A. Potamianou, M. Synodinou, N. Karvounis, A. Angelides, K. Chrysanthou, A. E. Athanassiou
Intraoperative electron beam radiotherapy followed by moderate doses of external beam radiotherapy in the treatment of resected soft tissue sarcomas of the extremities (pages 391 to 398)
E. Beroukas (Department of Radiation Oncology-B, Metaxa Cancer Hospital, Piraeus, Greece), E. Peponi, G. Soulimioti, Z. Kalaitzi, A. Potamianou, I. Skarlatos, G. Economou, A. E. Athanassiou, K. Beroukas
Local administration of interferon-alpha in cases of cervical intraepithelial neoplasia associated with human papillomavirus infection (pages 399 to 402)
G. Chakalova (Department of Gynecologic Oncology, National Oncological Center, Sofia, Bulgaria), G. Ganchev
Localization, clinical and pathological characteristics and survival in sporadic colon cancer patients younger than 40 and over 65 years of age (pages 403 to 408)
J. Josifovski (Department of Gastroenterology, Institute for Oncology and Radiology of Serbia, Beograd, Serbia and Montenegro), S. Stojanovi, L. Radocevi-Jeli, T. Josifovski
Evaluation of pulmonary complications of radiotherapy in breast cancer patients (pages 409 to 415)
Malas Oru (Department of Chest Diseases, Dr. Ltfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey), B. alayan, Z. cal, A. zkan, E. Torun, A. Mayadali
Survival of patients with resected pIIIa – N2 non small cell lung cancer suggestion for subclassification (pages 417 to 422)
G. Andjeli (Institute for Medical Research, Military Medical Academy, Beograd, Serbia and Montenegro), V. Stani, B. Guli, A. Ristanovi, V. Cvijanovi
Diagnostic procedures of pleural malignant mesothelioma our experience (pages 423 to 426)
J. Stojsic (Institute for Lung Diseases and Tuberculosis, Beograd, Serbia and Montenegro), Z. Spasic, M. Velinovic, T. Adzic, D. Maric, V. Todorovic, N. Drndarevic
Expression of galectin-3 and carcinoembryonic antigen in the trophoblast of the gestational trophoblastic disease (pages 427 to 432)
M. Boi (Institute for the Application of Nuclear Energy, INEP, Zemun-Belgrade, Serbia and Montenegro), S. Golubovi, M. Petronijevi, Lj. Viovac
G. D. Geromichalos (Symeonidio Research Center, Theagenio Cancer Hospital, Thessaloniki, Greece), G. A. Katsoulos, A. Papageorgiou, D. T.P. Trafalis, C. C. Hadjikostas, S. H. Voyatzi, P. Stravoravdi
Antioxidative and antiproliferative effects of Satureja montana L. extracts (pages 443 to 449)
D.D. etojevi-Simin (Institute of Oncology Sremska Kamenica, Department of Experimental Oncology, Sremska Kamenica, Serbia and Montenegro), J.M. anadanovi-Brunet, G. M. Bogdanovi, G. S. etkovi, V. T. Tumbas, S. M. Djilas
A comparison of Monte Carlo simulation with experimental dosimetric techniques for a 6 MV stereotactic radiotherapy unit (pages 451 to 464)
I. Tsougos (Department of Medical Physics, Medical School, University of Thessaly, Larissa, Hellas), K. Theodorou, M. A. Bazioglou, S. Stathakis, C. Kappas
Paget’s “seed and soil” hypothesis revisited (pages 465 to 467)
S. Amerasekera (Cambridge Breast Unit, Addenbrookes Hospital, Cambridge, United Kingdom), M. Turner, A. D. Purushotham
Peutz-Jeghers syndrome combined with breast cancer, cervical carcinoma and ovarian gonadoblastoma a case report (pages 469 to 472)
F. Tokatli (Department of Radiation Oncology, TrakyaUniversity, Faculty of Medicine, Edirne, Turkey), N. Tunbilek2, F. z Puyan, B. Denizli, K. Ibi, G. Bayir, K. Uygun
Ovarian fibrothecoma associated with Meigs’ syndrome and elevated serum CA 125 (pages 473 to 475)
D. P. Korkolis (First Department of Surgery, Hellenic Anticancer Institute, St. Savvas Hospital, Athens, Greece), G. V. Koulaxouzidis, N. Apostolikas, P. P. Vassilopoulos
Atypical presentation of an unusual lung tumor (pages 477 to 479)
M. Kaptanoglu (Departments of Thoracic Surgery, Cumhuriyet University, School of Medicine, Sivas, Turkey), A. Nadir, S. Arici, P. Hasleton
Primary cerebral gliosarcoma a case presentation with review of the literature (pages 481 to 484)
E. E. Pakos (Department of Radiation Therapy, University Hospital of Ioannina, School of Medicine, Ioannina, Greece), A. C. Goussia, E. J. Pitouli, P. G. Tsekeris
Paul Ehrlich (1854-1915) founder of chemotherapy and pioneer of haematology, immunology and oncology (pages 485 to 491)
G. Androutsos (Institute of History of Medicine, University Claude Bernard, Lyons, France)